Income Tax
Neurocrine Biosciences Income Tax decreased by 42.9% to $48.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 619.1%, from $6.80M to $48.90M. Over 3 years (FY 2022 to FY 2025), Income Tax shows an upward trend with a 56.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase relative to pre-tax income may signal a higher effective tax rate or changes in tax legislation, while a decrease may indicate tax benefits or lower jurisdictional rates.
Detailed definition
Represents the total provision for income taxes recognized by the company during the reporting period, including both cu...
Peer comparison
Highly dependent on the company's geographic footprint and tax planning strategies compared to peers.
income_tax_expenseHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.20M | $8.00M | $7.50M | -$6.40M | $29.40M | $28.90M | -$26.70M | $26.10M | $32.50M | $50.50M | -$8.90M | $33.60M | $60.50M | $59.50M | $6.80M | $52.00M | $82.30M | $85.70M | $48.90M |
| QoQ Change | — | -47.4% | -6.3% | -185.3% | +559.4% | -1.7% | -192.4% | +197.8% | +24.5% | +55.4% | -117.6% | +477.5% | +80.1% | -1.7% | -88.6% | +664.7% | +58.3% | +4.1% | -42.9% |
| YoY Change | — | — | — | -142.1% | +267.5% | — | -456.0% | +507.8% | +10.5% | +74.7% | +66.7% | +28.7% | +86.2% | +17.8% | +176.4% | +54.8% | +36.0% | +44.0% | +619.1% |
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Reportable Segment | $6.80M | $52.00M | $82.30M | $85.70M | $48.90M |
| Total | $6.80M | $52.00M | $82.30M | $85.70M | $48.90M |
Income Tax at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's income tax?
- Neurocrine Biosciences (NBIX) reported income tax of $48.90M in Q1 2026.
- How has Neurocrine Biosciences's income tax changed year-over-year?
- Neurocrine Biosciences's income tax increased by 619.1% year-over-year, from $6.80M to $48.90M.
- What is the long-term trend for Neurocrine Biosciences's income tax?
- Over 3 years (2022 to 2025), Neurocrine Biosciences's income tax has grown at a 56.3% compound annual growth rate (CAGR), from $59.40M to $226.80M.
- What does income tax mean?
- The total amount of income tax the company is required to pay on its earnings.